EcoDrugPlus

Tubulin Alpha 1b

Ensembl ID : ENSPLOG00000011373
Gene Symbol: TUBA1B
4 Cross references
195 Possible Orthologues:

Tubulin Alpha 3c

Ensembl ID : ENSPLOG00000014642
Gene Symbol: TUBA3C
4 Cross references
243 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPLOG00000016209
Gene Symbol: TUBA4A
4 Cross references
223 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPLOG00000012649
Gene Symbol: TUBB1
4 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSPLOG00000018497
Gene Symbol: TUBB2B
4 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPLOG00000013597
Gene Symbol: TUBB3
2 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSPLOG00000008766
Gene Symbol: TUBB4A
4 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPLOG00000020120
Gene Symbol: TUBB4B
4 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSPLOG00000020059
Gene Symbol: TUBB6
4 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPLOG00000016488
Gene Symbol: TUBB
4 Cross references
292 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPLOG00000020277
Gene Symbol: TP53
4 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPLOG00000017151
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).